Krishna Institute of Medical Sciences Limited — PPTs, 07-11-2025: Investor Presentation

KIMS Hospitals reported Q2 FY26 consolidated revenue of **INR 964.9 Cr**, a solid 23.3% YoY jump. However, EBITDA dipped 6.7% YoY to **INR 208.2 Cr**, with margins at 21.6% (vs 28.5% last year). Profit after tax (PAT) saw a 40.3% YoY decline to **INR 72 Cr**, and EPS followed suit, down 37.7% to **INR 1.67**. This dip in profitability is mainly due to the ramp-up phase of newly acquired and greenfield units. Operational metrics showed strength, with Inpatient volumes up 15.3% YoY and Outpatient volumes up 25.1% YoY, while ARPOB grew 9.8% YoY.

The company's strategy emphasizes network expansion, targeting 2100+ new beds through greenfield projects and O&M partnerships. Focus areas include providing affordable quality care, advanced transplant programs, and leveraging cutting-edge medical technology, alongside strategic doctor partnerships.

Recent developments include adding new capacities in Bengaluru, Srikakulam, and Sunshine in Q2 FY26. Significant ramp-up efforts continue in Maharashtra, Kerala, and Bengaluru. Notably, the new 300-bed Thane unit is expected to break even in the next two months, and KIMS PES in Bengaluru (361 beds) is slated to begin phased operations in November 2025.

Management's outlook points to continued expansion, with additional beds planned for Bengaluru, Ongole, Anantapur, Kondapur, and Rajahmundry in the coming quarters.